ORIGINAL RESEARCH article
Front. Trop. Dis.
Sec. Antimicrobial Resistance
Volume 6 - 2025 | doi: 10.3389/fitd.2025.1555008
This article is part of the Research TopicAntimicrobial Resistance Response Perspectives in AfricaView all 10 articles
Prescription and Antibiotic Resistance Patterns at Selected Critical Care Units of the Largest Teaching and Referral Hospital in Kenya
Provisionally accepted- 1Department of Medical Services, Public Health and Sanitation, County Government of Kisumu, Kisumu, Kenya
- 2Department of Pharmacology, Clinical Pharmacy, and Pharmacy Practice, College of Health Sciences, University of Nairobi, Nairobi, Kenya
- 3Department of Research and Training, Jaramogi Oginga Odinga Teaching and Referral Hospital, Kisumu, Kenya
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Little is known about the prescription and antibiotic resistance patterns at Kenyatta National Hospital (KNH)' s critical care units (CCUs). The present study aimed to evaluate these patterns at selected CCUs at KNH.This was a descriptive, retrospective cross-sectional study of selected CCUs at KNH between January and December 2017. Data on prescription and antibiotic resistance patterns were abstracted from the medical records of patients 13 years old admitted at selected CCUs at KNH during the study period.Results: 309 patients with a median age of 40.6 ±17.5 years were recruited; trauma was the leading cause of admission (72/309, 23.53%), and most were male (n=158, 51.1%). Antibiotic therapy was initiated before CCU admission in 304/309 (98.4%) of the patients, documentation of antibiotic indications was low for both empirical (25%) and targeted therapy (41.6%), and ceftriaxone (36.8%), metronidazole (16.9%), and meropenem (12.4%) were predominantly prescribed. Pre-therapy cultures were obtained in 51.1% of cases, with 42.7% yielding positive results and Klebsiella pneumonia (23.9%), Acinetobacter baumanii (16.4%), and Escherichia coli (10.5%) predominating. Furthermore, 67% (n=11) of K. pneumonia isolates were sensitive to meropenem, 82% (n=9) of Acinetobacter baumanii isolates were sensitive to amikacin, 55% (n=6) to meropenem and 27% (n=3) were sensitive to ceftazidime and cefepime. All the A. baumanii isolates were resistant to tigecycline, linezolid, and teicoplanin. Most (86%, n=6) of the E. coli isolates were sensitive to meropenem, 71% (n=5) were sensitive to amikacin, and 43% (n=3) were sensitive to gentamicin.The high rates of pre-CCU antibiotic initiation, low documentation of therapeutic indications, and widespread resistance to commonly used antibiotics at the Kenyatta National Hospital highlight the urgent need for improved antimicrobial stewardship programs. Moreover, the predominance of multi-drug resistant organisms, particularly K. pneumonia and A. baumanii, and their variable sensitivity patterns to reserve antibiotics like meropenem suggests there is need for regular surveillance and update of antibiotic guidelines.
Keywords: Bacterial profile, Prescription patterns, Antibiotic resistance patterns, Critical care units, Kenyatta National Hospital
Received: 03 Jan 2025; Accepted: 28 Jul 2025.
Copyright: © 2025 Obegi, Oluka, Opanga, Aywak, Okalebo and Okumu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Emmah Obegi, Department of Medical Services, Public Health and Sanitation, County Government of Kisumu, Kisumu, Kenya
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.